ResearcherUniversity of South FloridaNo recent work listed
Paul G. Toomey
Matched on OpenAlex author ID A5034424247. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper
Papers 4
- Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. Co-author DOI 10.1097/ij9.0000000000000015↗
- Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1177/000313481307900818↗
- Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who undergo distal pancreatectomy and splene… Co-author DOI 10.1007/s11605-011-1765-6↗
- Survival after pancreatectomy for pancreatic adenocarcinoma is not impacted by performance status. Co-author DOI 10.1016/j.amjsurg.2012.01.016↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alexander S. Rosemurgy · 4 shared papers, 2012–2017 · strength 0.19
- Paper Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. DOI 10.1097/ij9.0000000000000015↗
- Paper Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1177/000313481307900818↗
- Paper Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who … DOI 10.1007/s11605-011-1765-6↗
- Kenneth Luberice · 3 shared papers, 2012–2017 · strength 0.16
- Paper Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. DOI 10.1097/ij9.0000000000000015↗
- Paper Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1177/000313481307900818↗
- Paper Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who … DOI 10.1007/s11605-011-1765-6↗
- Sharona B Ross · 3 shared papers, 2012–2017 · strength 0.16
- Paper Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. DOI 10.1097/ij9.0000000000000015↗
- Paper Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1177/000313481307900818↗
- Paper Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who … DOI 10.1007/s11605-011-1765-6↗
- Jonathan Matthew Hernandez · 2 shared papers, 2012 · strength 0.07
- John E. Mullinax · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.